Literature DB >> 11726834

Hyperuricemia, gout, and renal function after liver transplantation.

D A Neal1, B D Tom, A E Gimson, P Gibbs, G J Alexander.   

Abstract

BACKGROUND: Hyperuricemia is a recognized complication of renal and cardiac transplantation, but the development of hyperuricemia and gout following liver transplantation have received less attention. We have retrospectively assessed the prevalence of hyperuricemia in 134 consecutive liver transplant recipients.
RESULTS: Forty-seven percent of the liver transplant recipients studied had hyperuricemia. Serum creatinine was higher in hyperuricemic than in nonhyperuricemic patients. Peak uric acid correlated significantly with corresponding serum creatinine (rs=0.694). Only 6% developed gout. All the patients with gout and 10 hyperuricemic patients with renal impairment but without gout were treated with allopurinol. Over a median period of 3 months, mean serum creatinine fell from 177 micromol/l to 160 micromol/l (P=0.01), without change in type or dose of immuno-suppression.
CONCLUSIONS: There is an important association between liver transplantation and hyperuricemia. Treatment with allopurinol results in a significant reduction in serum creatinine in patients with gout and in those with hyperuricemia and renal impairment.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11726834     DOI: 10.1097/00007890-200111270-00021

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  16 in total

1.  Hyperuricemia and gout following pediatric renal transplantation.

Authors:  Giuseppina Spartà; Markus J Kemper; Thomas J Neuhaus
Journal:  Pediatr Nephrol       Date:  2006-09-01       Impact factor: 3.714

Review 2.  Gout in solid organ transplantation: a challenging clinical problem.

Authors:  Lisa Stamp; Martin Searle; John O'Donnell; Peter Chapman
Journal:  Drugs       Date:  2005       Impact factor: 9.546

3.  Uric acid and chronic kidney disease: A time to act?

Authors:  Gianni Bellomo
Journal:  World J Nephrol       Date:  2013-05-06

4.  Use of uric acid-lowering agents limits experimental cyclosporine nephropathy.

Authors:  Fernanda Cristina Mazali; Richard J Johnson; Marilda Mazzali
Journal:  Nephron Exp Nephrol       Date:  2011-11-25

Review 5.  Long-term medical management of the liver transplant recipient: what the primary care physician needs to know.

Authors:  Siddharth Singh; Kymberly D Watt
Journal:  Mayo Clin Proc       Date:  2012-07-03       Impact factor: 7.616

Review 6.  Challenges of conducting a trial of uric-acid-lowering therapy in CKD.

Authors:  Sunil V Badve; Fiona Brown; Carmel M Hawley; David W Johnson; John Kanellis; Gopala K Rangan; Vlado Perkovic
Journal:  Nat Rev Nephrol       Date:  2011-02-15       Impact factor: 28.314

Review 7.  Gout and organ transplantation.

Authors:  Lisa K Stamp; Peter T Chapman
Journal:  Curr Rheumatol Rep       Date:  2012-04       Impact factor: 4.592

8.  Hyperuricemia beyond 1 year after kidney transplantation in pediatric patients: Prevalence and risk factors.

Authors:  B Einollahi; H Einollahi; Z Rostami
Journal:  Indian J Nephrol       Date:  2012-07

9.  Efficacy and safety of febuxostat in the treatment of hyperuricemia in stable kidney transplant recipients.

Authors:  Tadashi Sofue; Masashi Inui; Taiga Hara; Yoko Nishijima; Kumiko Moriwaki; Yushi Hayashida; Nobufumi Ueda; Akira Nishiyama; Yoshiyuki Kakehi; Masakazu Kohno
Journal:  Drug Des Devel Ther       Date:  2014-02-17       Impact factor: 4.162

Review 10.  The role of uric acid in kidney fibrosis: experimental evidences for the causal relationship.

Authors:  Il Young Kim; Dong Won Lee; Soo Bong Lee; Ihm Soo Kwak
Journal:  Biomed Res Int       Date:  2014-05-05       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.